Editorial: Update on the Treatment of Metastatic Non-small Cell Lung Cancer (NSCLC) in New Era of Personalised Medicine

Bibliographic Details
Main Author: Barbara Melosky
Format: Article
Language:English
Published: Frontiers Media S.A. 2017-12-01
Series:Frontiers in Oncology
Subjects:
Online Access:http://journal.frontiersin.org/article/10.3389/fonc.2017.00311/full
id doaj-a3752e4e26994736b11c6fc50aa6ec5a
record_format Article
spelling doaj-a3752e4e26994736b11c6fc50aa6ec5a2020-11-24T22:19:39ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2017-12-01710.3389/fonc.2017.00311323997Editorial: Update on the Treatment of Metastatic Non-small Cell Lung Cancer (NSCLC) in New Era of Personalised MedicineBarbara Melosky0University of British Columbia, Vancouver, BC, Canadahttp://journal.frontiersin.org/article/10.3389/fonc.2017.00311/fullNSCLCadvancedtargeted therapyimmunotherapyeditorial
collection DOAJ
language English
format Article
sources DOAJ
author Barbara Melosky
spellingShingle Barbara Melosky
Editorial: Update on the Treatment of Metastatic Non-small Cell Lung Cancer (NSCLC) in New Era of Personalised Medicine
Frontiers in Oncology
NSCLC
advanced
targeted therapy
immunotherapy
editorial
author_facet Barbara Melosky
author_sort Barbara Melosky
title Editorial: Update on the Treatment of Metastatic Non-small Cell Lung Cancer (NSCLC) in New Era of Personalised Medicine
title_short Editorial: Update on the Treatment of Metastatic Non-small Cell Lung Cancer (NSCLC) in New Era of Personalised Medicine
title_full Editorial: Update on the Treatment of Metastatic Non-small Cell Lung Cancer (NSCLC) in New Era of Personalised Medicine
title_fullStr Editorial: Update on the Treatment of Metastatic Non-small Cell Lung Cancer (NSCLC) in New Era of Personalised Medicine
title_full_unstemmed Editorial: Update on the Treatment of Metastatic Non-small Cell Lung Cancer (NSCLC) in New Era of Personalised Medicine
title_sort editorial: update on the treatment of metastatic non-small cell lung cancer (nsclc) in new era of personalised medicine
publisher Frontiers Media S.A.
series Frontiers in Oncology
issn 2234-943X
publishDate 2017-12-01
topic NSCLC
advanced
targeted therapy
immunotherapy
editorial
url http://journal.frontiersin.org/article/10.3389/fonc.2017.00311/full
work_keys_str_mv AT barbaramelosky editorialupdateonthetreatmentofmetastaticnonsmallcelllungcancernsclcinneweraofpersonalisedmedicine
_version_ 1725778030057488384